Alimta, Eli Lilly’s cash cow drug for lung cancer treatment is under attack. Interestingly, Lilly is attempting to defend Alimta’s patent with vitamins! Vitamins are typically discouraged when taking chemotherapy because they interfere with the effectiveness of the drug. Alimta is different. This lung cancer drug requires vitamin treatment. Why? To prevent the drug from … Continue reading Lilly’s Lung Cancer Drug Requires Vitamins To Reduce Death Rate